Skip to main
ZBIO

ZBIO Earnings Dates & Reports

ZBIO Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$1.54
Actual EPS-$1.46
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ZBIO Earnings per Share (EPS) History

Signup for full access
Browse free

ZBIO Latest Earnings

The value each ZBIO share was expected to gain vs. the value each share gained.

ZBIO reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$1.46. This exceeded analysts' expectations of -$1.54 by 5.19%, marking a Beat.

For comparison, Zenas Biopharma Inc reported EPS of -$0.80 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$1.27.

ZBIO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2026
-$1.27
Q1 2026
-$1.54-$1.46-5.19%
Q4 2025
-$4.54
Q3 2025
-$0.98-$1.22+24.49%
Q2 2025
-$1.04-$1.25+20.19%
View all

ZBIO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Zenas Biopharma Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

ZBIO Earnings FAQs

ZBIO last reported earnings on May 13, 2026 for Q1 2026, posting an EPS of -$1.46, which Beat the estimate of -$1.54 by 5.19%.

For Q1 2026, ZBIO reported an EPS of -$1.46, exceeding analysts' estimate of -$1.54 by 5.19%.

For Q1 2026, ZBIO Beat expectations with an actual EPS of -$1.46 vs. an estimated EPS of -$1.54.

Following the last earnings report on May 13, 2026, ZBIO's stock price moved — from — to —.

The next ZBIO earnings call is scheduled for Mar. 15, 2027, where executives will discuss financial results and outlook.

Zenas Biopharma Inc (ZBIO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.